Wedbush Downgrades Nuvalent to Neutral, Lowers Price Target to $124

Benzinga Newsdesk www.benzinga.com Negative 85.2%

Neg 85.2% Neu 0% Pos 0%

Wedbush analyst David Nierengarten downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Neutral and lowers the price target from $125 to $124.